145 related articles for article (PubMed ID: 8232077)
1. Ifosfamide-induced subclinical nephrotoxicity and its potentiation by cisplatinum.
Rossi R; Danzebrink S; Hillebrand D; Linnenbürger K; Ullrich K; Jürgens H
Med Pediatr Oncol; 1994; 22(1):27-32. PubMed ID: 8232077
[TBL] [Abstract][Full Text] [Related]
2. [Ifosfamide-induced nephrotoxicity].
Rossi R; Rath B; Ullrich K; Ehrich JH
Monatsschr Kinderheilkd; 1993 Jul; 141(7):594-601. PubMed ID: 8413339
[TBL] [Abstract][Full Text] [Related]
3. Estimation of ifosfamide/cisplatinum-induced renal toxicity by urinary protein analysis.
Rossi RM; Kist C; Wurster U; Külpmann WR; Ehrich JH
Pediatr Nephrol; 1994 Apr; 8(2):151-6. PubMed ID: 8018491
[TBL] [Abstract][Full Text] [Related]
4. Development of ifosfamide-induced nephrotoxicity: prospective follow-up in 75 patients.
Rossi R; Pleyer J; Schäfers P; Kuhn N; Kleta R; Deufel T; Jürgens H
Med Pediatr Oncol; 1999 Mar; 32(3):177-82. PubMed ID: 10064184
[TBL] [Abstract][Full Text] [Related]
5. Unilateral nephrectomy and cisplatin as risk factors of ifosfamide-induced nephrotoxicity: analysis of 120 patients.
Rossi R; Gödde A; Kleinebrand A; Riepenhausen M; Boos J; Ritter J; Jürgens H
J Clin Oncol; 1994 Jan; 12(1):159-65. PubMed ID: 8270973
[TBL] [Abstract][Full Text] [Related]
6. Partial and complete de Toni-Debré-Fanconi syndrome after ifosfamide chemotherapy of childhood malignancy.
Rossi R; Ehrich JH
Eur J Clin Pharmacol; 1993; 44 Suppl 1():S43-5. PubMed ID: 8486147
[TBL] [Abstract][Full Text] [Related]
7. The influence of age on nephrotoxicity following chemotherapy in children.
Skinner R; Pearson AD; Price L; Coulthard MG; Craft AW
Br J Cancer Suppl; 1992 Aug; 18():S30-5. PubMed ID: 1503924
[TBL] [Abstract][Full Text] [Related]
8. The utility of (99m)Tc-DMSA and Tc(99m)-EC scintigraphy for early diagnosis of ifosfamide induced nephrotoxicity.
Caglar M; Yarís N; Akyuz C
Nucl Med Commun; 2001 Dec; 22(12):1325-32. PubMed ID: 11711903
[TBL] [Abstract][Full Text] [Related]
9. Tubular function and histological findings in ifosfamide-induced renal Fanconi syndrome--a report of two cases.
Rossi R; Helmchen U; Schellong G
Eur J Pediatr; 1992 May; 151(5):384-7. PubMed ID: 1396897
[TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up of ifosfamide renal toxicity in children treated for malignant mesenchymal tumors: an International Society of Pediatric Oncology report.
Suarez A; McDowell H; Niaudet P; Comoy E; Flamant F
J Clin Oncol; 1991 Dec; 9(12):2177-82. PubMed ID: 1720453
[TBL] [Abstract][Full Text] [Related]
11. Potentiation of ifosfamide neurotoxicity, hematotoxicity, and tubular nephrotoxicity by prior cis-diamminedichloroplatinum(II) therapy.
Goren MP; Wright RK; Pratt CB; Horowitz ME; Dodge RK; Viar MJ; Kovnar EH
Cancer Res; 1987 Mar; 47(5):1457-60. PubMed ID: 3815347
[TBL] [Abstract][Full Text] [Related]
12. Concentrating capacity in ifosfamide-induced severe renal dysfunction.
Rossi R; Gödde A; Kleinebrand A; Rath B; Jürgens H
Ren Fail; 1995 Sep; 17(5):551-7. PubMed ID: 8570867
[TBL] [Abstract][Full Text] [Related]
13. [Nephrotoxicity of ifosfamide with special reference to Fanconi Syndrome].
Rogowska E; Woźniak W
Med Wieku Rozwoj; 2004; 8(2 Pt 1):289-95. PubMed ID: 15738605
[TBL] [Abstract][Full Text] [Related]
14. A prospective evaluation of ifosfamide-related nephrotoxicity in children and young adults.
Ho PT; Zimmerman K; Wexler LH; Blaney S; Jarosinski P; Weaver-McClure L; Izraeli S; Balis FM
Cancer; 1995 Dec; 76(12):2557-64. PubMed ID: 8625085
[TBL] [Abstract][Full Text] [Related]
15. Renal function following combination chemotherapy with ifosfamide and cisplatin in patients with osteogenic sarcoma.
Arndt C; Morgenstern B; Hawkins D; Wilson D; Liedtke R; Miser J
Med Pediatr Oncol; 1999 Feb; 32(2):93-6. PubMed ID: 9950195
[TBL] [Abstract][Full Text] [Related]
16. Ifosfamide-induced renal tubular dysfunction and rickets in children with Wilms tumor.
Burk CD; Restaino I; Kaplan BS; Meadows AT
J Pediatr; 1990 Aug; 117(2 Pt 1):331-5. PubMed ID: 2166154
[TBL] [Abstract][Full Text] [Related]
17. Renal function in children and adolescents following 72 g/m2 of ifosfamide.
Arndt C; Morgenstern B; Wilson D; Liedtke R; Miser J
Cancer Chemother Pharmacol; 1994; 34(5):431-3. PubMed ID: 8070011
[TBL] [Abstract][Full Text] [Related]
18. Renal function abnormalities after ifosfamide treatment in children.
De Schepper J; Hachimi-Idrissi S; Verboven M; Piepsz A; Otten J
Acta Paediatr; 1993 Apr; 82(4):373-6. PubMed ID: 8318805
[TBL] [Abstract][Full Text] [Related]
19. Children's toxicology from bench to bed--Drug-induced renal injury (2): Nephrotoxicity induced by cisplatin and ifosfamide in children.
Fujieda M; Matsunaga A; Hayashi A; Tauchi H; Chayama K; Sekine T
J Toxicol Sci; 2009; 34 Suppl 2():SP251-7. PubMed ID: 19571477
[TBL] [Abstract][Full Text] [Related]
20. Nephrotoxicity associated with ifosfamide.
Smeitink J; Verreussel M; Schröder C; Lippens R
Eur J Pediatr; 1988 Nov; 148(2):164-6. PubMed ID: 3234441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
